Analysis of telomerase activity in ovarian cystadenomas, low-malignant- potential tumors, and invasive carcinomas

Gynecologic Oncology

Volumn 74, Issue 3, 1999, Pages 338-345

  Datar, Ram H ^a   Naritoku, Wesley Y ^a   Li, Peili ^a   Tsao Wei, Denice ^a   Groshen, Susan ^a   Taylor, Clive R ^a   Imam, S Ashraf ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

Author keywords

Low malignant potential ovarian tumor; Ovarian cancer; Telomerase

Indexed keywords

TELOMERASE;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CYSTADENOCARCINOMA; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032823839     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5506     Document Type: Article

References (19)

1. Auersperg N, Maines-Bandiera S, Booth JH, Lynch HT, Godwin AK, Hamilton TC: Expression of two mucin antigens in cultured human ovarian surface epithelium: Influence of a family history of ovarian cancer. Am J Obstet Gynecol 173:558-565, 1995
2. Scully RE: Pathology of ovarian cancer precursors. J Cell Biochem (Suppl) 23:208-218, 1995
3. Kempson RL, Hendrikson MR: Miscellaneous types of surface epithelial neoplasms: The well-differentiated end of the morphologic spectrum of endometrioid, clear-cell, and Brenner tumors and mixed epithelial tumors of low malignant potential of Mullerian type. Pathology 1:335-365, 1993
4. Scollo P, Pagano MR: Borderline ovarian tumors: Case reports and review of literature. Eur J Gynecol Oncol 16:232-237, 1995
5. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994
6. Counter CM, Hirte HW, Bacchetti S, Harley CB: Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 91:2900-2904, 1994
7. Tang R, Cheng A-J, Wang J-Y, Wang T-CV: Close correlation between telomerase expression and adenomatous polyp progression in multistep colorectal carcinogenesis. Cancer Res 58:4052-4054, 1998
8. Zheng PS, Iwasaka T, Yamasaki F, Ouchida M, Yokoyama M, Nakao Y, Fukuda K, Matsuyama T, Sugimori H: Telomerase activity in gynecologic tumors. Gynecol Oncol 64:171-175, 1997
9. Wan M, Li WZ, Duggan BD, Felix JC, Zhao Y, Dubeau L: Telomerase activity in benign and malignant epithelial ovarian tumors. J Natl Cancer Inst 89:437-441, 1997
10. Oishi T, Kigawa J, Minagawa Y, Shimada M, Takahashi M, Terakawa N: Alteration of telomerase activity associated with development and extension of epithelial ovarian cancer. Obstet Gynecol 91:568-571, 1998
11. Rhyu MS: Telomeres, telomerase, and immortality. J Natl Cancer Inst 87:884-894, 1995
12. Imam SA, Kim MS, Anker L, Datar RH, Law RE, Taylor CR: Systematic determination of telomerase activity and telomere length during the progression of human breast cancer in cell culture model. Anticancer Res 17:4435-4441, 1997
13. Miller RG: Survival Analysis, New York, Wiley, 1981
14. Zakian VA: Structure and function of telomeres. Annu Rev Genet 23: 579-604, 1989
15. Shay JW, Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 33:787-791, 1997
16. Duggan BD, Wan M, Yu MC, Roman LD, Muderspach LI, Delgadillo E, Li WZ, Martin SE, Dubeau L: Detection of ovarian cancer cells: Comparison of a telomerase assay and cytologic examination. J Natl Cancer Inst 90:238-242, 1998
17. Kyo S, Takakura M, Tanaka M, Murakami K, Saitoh R, Hirano H, Inoue M: Quantitative differences in telomerase activity among malignant, premalignant and benign ovarian lesions. Clin Cancer Res 4:399-405, 1998
18. Ogami M, Ikura Y, Nishiguchi S, Kuroki T, Ueda M, Sakurai M: Quantitative analysis and in situ localization of human telomerase RNA in chronic liver disease and hepatocellular carcinoma. Lab Invest 79:15-26, 1999
19. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR: Evidence of an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nature (Medicine) 3:1271-1274, 1997